Benefits of Glucagon-Like Peptide-1 Agonists Use in Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Abboud, Alan [1 ]
Aksan, Feyzullah [2 ]
Monzur, Farah [3 ]
机构：
[1] Stony Brook Univ Hosp, Ramsey, NJ USA
[2] SUNY Stony Brook, Renaissance Sch Med, Port Jefferson Stn, NY USA
[3] SUNY Stony Brook, Renaissance Sch Med, Stony Brook, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034412.42810.c5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1261
引用
收藏
页码：S899 / S899
页数：1
相关论文
共 50 条
  • [41] Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity
    Jensterle, Mojca
    Janez, Andrej
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06): : 599 - 608
  • [42] Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
    Heymann, Warren R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (01) : 29 - 30
  • [43] Glucagon-like peptide-1 receptor agonists in neoplastic diseases
    Ji, Lisan
    He, Xianzhen
    Min, Xinwen
    Yang, Handong
    Wu, Wenwen
    Xu, Hao
    Chen, Jun
    Mei, Aihua
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [44] Clinical pharmacology of glucagon-like peptide-1 receptor agonists
    Sfairopoulos, Dimitrios
    Liatis, Stavros
    Tigas, Stelios
    Liberopoulos, Evangelos
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 17 (03): : 333 - 350
  • [45] Renal protection with glucagon-like peptide-1 receptor agonists
    Vitale, Martina
    Haxhi, Jonida
    Cirrito, Tiziana
    Pugliese, Giuseppe
    CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 91 - 101
  • [46] UTILIZATION OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN CANADA
    Vannabouathong, C.
    Le, K.
    Dyrda, P.
    VALUE IN HEALTH, 2023, 26 (06) : S217 - S217
  • [47] Clinical pharmacology of glucagon-like peptide-1 receptor agonists
    Dimitrios Sfairopoulos
    Stavros Liatis
    Stelios Tigas
    Evangelos Liberopoulos
    Hormones, 2018, 17 : 333 - 350
  • [48] Glucagon-like peptide-1 receptor agonists and aspiration risk
    McIsaac, Daniel I.
    Bryson, Gregory L.
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 387
  • [49] Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
    Kang, Yu Mi
    Jung, Chang Hee
    ENDOCRINOLOGY AND METABOLISM, 2016, 31 (02) : 258 - 274
  • [50] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
12345